Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Chamberlain

Showing results (101-110 of 244) with videos related to

Pageof 25
Sort By:
Neuro-Oncology|August 10, 2020
Leptomeningeal metastases: how best to assess responseMarc C Chamberlain
Neuro-Oncology|June 22, 2014
Is the volume of low-grade glioma measurable and is it clinically relevant?Marc C Chamberlain
Expert Review of Neurotherapeutics|April 7, 2010
Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeabilityMarc C Chamberlain
Expert Review of Neurotherapeutics|April 7, 2010
Brain metastases: a medical neuro-oncology perspectiveMarc C Chamberlain
Hematology/Oncology Clinics of North America|July 17, 2012
Neoplastic meningitis and metastatic epidural spinal cord compressionMarc C Chamberlain
Cancer|August 14, 2002
A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitisMarc C Chamberlain
Cancer|February 7, 2009
Bevacizumab for recurrent alkylator-refractory anaplastic oligodendrogliomaMarc C Chamberlain, Sandra Johnston
Neurology|May 13, 2015
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classesMarc C Chamberlain, Marc Sanson
Handbook of Clinical Neurology|January 9, 2018
Leptomeningeal metastasisSophie Taillibert, Marc C Chamberlain
Journal of Neuro-Oncology|October 5, 2006
A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastomaMarc C Chamberlain, Lisa Chalmers
Pageof 25

Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Neuro-Oncology|August 10, 2020
Leptomeningeal metastases: how best to assess responseMarc C Chamberlain
Neuro-Oncology|June 22, 2014
Is the volume of low-grade glioma measurable and is it clinically relevant?Marc C Chamberlain
Expert Review of Neurotherapeutics|April 7, 2010
Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeabilityMarc C Chamberlain
Expert Review of Neurotherapeutics|April 7, 2010
Brain metastases: a medical neuro-oncology perspectiveMarc C Chamberlain
Hematology/Oncology Clinics of North America|July 17, 2012
Neoplastic meningitis and metastatic epidural spinal cord compressionMarc C Chamberlain
Cancer|August 14, 2002
A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitisMarc C Chamberlain
Cancer|February 7, 2009
Bevacizumab for recurrent alkylator-refractory anaplastic oligodendrogliomaMarc C Chamberlain, Sandra Johnston
Neurology|May 13, 2015
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classesMarc C Chamberlain, Marc Sanson
Handbook of Clinical Neurology|January 9, 2018
Leptomeningeal metastasisSophie Taillibert, Marc C Chamberlain
Journal of Neuro-Oncology|October 5, 2006
A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastomaMarc C Chamberlain, Lisa Chalmers
Pageof 25